Iain M. Cockburn

Names

Identifer

Contact

Affiliations

• National Bureau of Economic Research (NBER) (weight: 20%)
  • EDIRC entry
  • location:
• Boston University / Questrom School of Business / Department of Strategy and Innovation (weight: 80%)
  • EDIRC entry
  • location:

Research profile

author of:

• Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research
  Annals of Economics and Statistics, GENES (2005)
  by Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson
  (ReDIF-article, adr:anecst:y:2005:i:79-80:p:165-188)
• Patents and the Global Diffusion of New Drugs
  American Economic Review, American Economic Association (2016)
  by Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman
  (ReDIF-article, aea:aecrev:v:106:y:2016:i:1:p:136-64)
• Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents
  American Economic Review, American Economic Association (1988)
  by Cockburn, Iain & Griliches, Zvi
  (ReDIF-article, aea:aecrev:v:78:y:1988:i:2:p:419-23)
• Generics and New Goods in Pharmaceutical Price Indexes
  American Economic Review, American Economic Association (1994)
  by Griliches, Zvi & Cockburn, Iain
  (ReDIF-article, aea:aecrev:v:84:y:1994:i:5:p:1213-32)
• Generics and New Goods in Pharmaceutical Price Indexes: Reply
  American Economic Review, American Economic Association (1997)
  by Griliches, Zvi & Cockburn, Iain
  (ReDIF-article, aea:aecrev:v:87:y:1997:i:4:p:768)
• Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach
  Journal of Business & Economic Statistics, American Statistical Association (1998)
  by Wang, Peiming & Cockburn, Iain M & Puterman, Martin L
  (ReDIF-article, bes:jnlbes:v:16:y:1998:i:1:p:27-41)
• Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs
  Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution (1996)
  by Ernst R. Berndt & Iain M. Cockburn & Zvi Griliches
  (ReDIF-article, bin:bpeajo:v:27:y:1996:i:1996-3:p:133-199)
• Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs
  Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution (1996)
  by Ernst R. Berndt & Iain M. Cockburn & Zvi Griliches
  (ReDIF-article, bin:bpeajo:v:27:y:1996:i:1996-3:p:201-267)
• Patents, Thickets and the Financing of Early‐Stage Firms: Evidence from the Software Industry
  Journal of Economics & Management Strategy, Wiley Blackwell (2009)
  by Iain M. Cockburn & Megan J. MacGarvie
  (ReDIF-article, bla:jemstr:v:18:y:2009:i:3:p:729-773)
• Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery
  Journal of Economics & Management Strategy, Wiley Blackwell (1994)
  by Cockburn, Iain & Henderson, Rebecca
  (ReDIF-article, bla:jemstr:v:3:y:1994:i:3:p:481-519)
• Unknown item RePEc:bla:jemstr:v:3:y:1994:i:3:p:481-519:a (article)
• Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
  Journal of Industrial Economics, Wiley Blackwell (1998)
  by Iain M. Cockburn & Rebecca M. Henderson
  (ReDIF-article, bla:jindec:v:46:y:1998:i:2:p:157-182)
• Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
  Strategic Management Journal, Wiley Blackwell (1994)
  by Rebecca Henderson & Iain Cockburn
  (ReDIF-article, bla:stratm:v:15:y:1994:i:s1:p:63-84)
• Untangling the origins of competitive advantage
  Strategic Management Journal, Wiley Blackwell (2000)
  by Iain M. Cockburn & Rebecca M. Henderson & Scott Stern
  (ReDIF-article, bla:stratm:v:21:y:2000:i:10-11:p:1123-1145)
• Deals not done: Sources of failure in the market for ideas
  Strategic Management Journal, Wiley Blackwell (2015)
  by Ajay Agrawal & Iain Cockburn & Laurina Zhang
  (ReDIF-article, bla:stratm:v:36:y:2015:i:7:p:976-986)
• Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy
  Capitalism and Society, De Gruyter (2010)
  by Cockburn Iain M. & Stern Scott
  (ReDIF-article, bpj:capsoc:v:5:y:2010:i:1:n:1)
• Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
  Forum for Health Economics & Policy, De Gruyter (1998)
  by Berndt Ernst R. & Cockburn Iain M. & Cocks Douglas L. & Epstein Arnold M. & Griliches Zvi
  (ReDIF-article, bpj:fhecpo:v:1:y:1998:n:3)
• Patents and the Global Diffusion of New Drugs
  CEP Discussion Papers, Centre for Economic Performance, LSE (2014)
  by Iain Cockburn & Jean O. Lanjouw & Mark Schankerman
  (ReDIF-paper, cep:cepdps:dp1298)
• Patents and the Global Diffusion of New Drugs
  CEPR Discussion Papers, C.E.P.R. Discussion Papers (2014)
  by Schankerman, Mark & Cockburn, Iain M & Lanjouw, Jean
  (ReDIF-paper, cpr:ceprdp:10149)
• Why are some regions more innovative than others? The role of firm size diversity
  CEPR Discussion Papers, C.E.P.R. Discussion Papers (2013)
  by Cockburn, Iain M & Agrawal, Ajay & Galasso, Alberto & Oettl, Alexander
  (ReDIF-paper, cpr:ceprdp:9766)
• The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems
  International Journal of Industrial Organization, Elsevier (2003)
  by Agrawal, Ajay & Cockburn, Iain
  (ReDIF-article, eee:indorg:v:21:y:2003:i:9:p:1227-1253)
• Opportunity costs and entrepreneurial activity
  Journal of Business Venturing, Elsevier (1995)
  by Amit, Raphael & Muller, Eitan & Cockburn, Iain
  (ReDIF-article, eee:jbvent:v:10:y:1995:i:2:p:95-106)
• Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
  Journal of Health Economics, Elsevier (2001)
  by Cockburn, Iain M. & Henderson, Rebecca M.
  (ReDIF-article, eee:jhecon:v:20:y:2001:i:6:p:1033-1057)
• Not Invented Here? Innovation in company towns
  Journal of Urban Economics, Elsevier (2010)
  by Agrawal, Ajay & Cockburn, Iain & Rosell, Carlos
  (ReDIF-article, eee:juecon:v:67:y:2010:i:1:p:78-89)
• Why are some regions more innovative than others? The role of small firms in the presence of large labs
  Journal of Urban Economics, Elsevier (2014)
  by Agrawal, Ajay & Cockburn, Iain & Galasso, Alberto & Oettl, Alexander
  (ReDIF-article, eee:juecon:v:81:y:2014:i:c:p:149-165)
• Patents and the survival of Internet-related IPOs
  Research Policy, Elsevier (2010)
  by Wagner, S. & Cockburn, I.
  (ReDIF-article, eee:respol:v:39:y:2010:i:2:p:214-228)
• Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms
  Research Policy, Elsevier (2013)
  by Mueller, Elisabeth & Cockburn, Iain M. & MacGarvie, Megan
  (ReDIF-article, eee:respol:v:42:y:2013:i:2:p:529-541)
• New Pills for Poor People? Empirical Evidence after GATT
  World Development, Elsevier (2001)
  by Lanjouw, Jean O. & Cockburn, Iain M.
  (ReDIF-article, eee:wdevel:v:29:y:2001:i:2:p:265-289)
• Patents and the global diffusion of new drugs
  LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library (2014)
  by Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark
  (ReDIF-paper, ehl:lserod:60450)
• Patents and the global diffusion of new drugs
  LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library (2016)
  by Cockburn, Iain & Lanjouw, Jean O. & Schankerman, Mark
  (ReDIF-paper, ehl:lserod:65415)
• Comments on Nathan Rosenberg’s ‘Critical Episodes in the Progress of Medical Innovation’
  Chapters, Edward Elgar Publishing (2009)
  by Iain M. Cockburn
  (ReDIF-chapter, elg:eechap:13445_11)
• Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity
  Information Systems Research, INFORMS (2012)
  by Landon Kleis & Paul Chwelos & Ronald V. Ramirez & Iain Cockburn
  (ReDIF-article, inm:orisre:v:23:y:2012:i:1:p:42-59)
• Entry and Patenting in the Software Industry
  Management Science, INFORMS (2011)
  by Iain M. Cockburn & Megan J. MacGarvie
  (ReDIF-article, inm:ormnsc:v:57:y:2011:i:5:p:915-933)
• Scale, scope and spillovers : the determinants of research productivity in ethical drug discovery
  Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management (1993)
  by Henderson, Rebecca. & Cockburn, Iain.
  (ReDIF-paper, mit:sloanp:2499)
• Racing or spilling? : the determinants of research productivity in ethical drug discovery
  Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management (1993)
  by Henderson, Rebecca. & Cockburn, Iain.
  (ReDIF-paper, mit:sloanp:2501)
• Racing to invest? : the dynamics of competition in ethical drug discovery
  Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management (1994)
  by Cockburn, Iain. & Henderson, Iain.
  (ReDIF-paper, mit:sloanp:2522)
• Measuring competence? : exploring firm effects in pharmaceutical research
  Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management (1994)
  by Henderson, Rebecca. & Cockburn, Iain.
  (ReDIF-paper, mit:sloanp:2524)
• Characteristics of Demand for Pharmaceutical Products : an Examination of four Cephalosporins
  Working papers, Massachusetts Institute of Technology (MIT), Department of Economics (1996)
  by Ellison, S & Cockburn, I & Griliches, A & Hausman, J
  (ReDIF-paper, mit:worpap:96-24)
• Is the Pharmaceutical Industry in a Productivity Crisis?
  NBER Chapters, National Bureau of Economic Research, Inc (2007)
  by Iain M. Cockburn
  (ReDIF-chapter, nbr:nberch:0032)
• Publicly Funded Science and the Productivity of the Pharmaceutical Industry
  NBER Chapters, National Bureau of Economic Research, Inc (2001)
  by Iain M. Cockburn & Rebecca M. Henderson
  (ReDIF-chapter, nbr:nberch:10775)
• Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D
  NBER Chapters, National Bureau of Economic Research, Inc (2011)
  by Iain M. Cockburn & Scott Stern & Jack Zausner
  (ReDIF-chapter, nbr:nberch:11749)
• The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions
  NBER Chapters, National Bureau of Economic Research, Inc (2010)
  by Iain M. Cockburn & Matthew J. Slaughter
  (ReDIF-chapter, nbr:nberch:11767)
• Not Invented Here? Innovation in Company Towns
  NBER Chapters, National Bureau of Economic Research, Inc (2010)
  by Ajay Agrawal & Iain Cockburn & Carlos Rosell
  (ReDIF-chapter, nbr:nberch:11890)
• Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research
  NBER Chapters, National Bureau of Economic Research, Inc (2010)
  by Jeffrey L. Furman & Margaret K. Kyle & Iain Cockburn & Rebecca M. Henderson
  (ReDIF-chapter, nbr:nberch:12232)
• Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort"
  NBER Chapters, National Bureau of Economic Research, Inc (2011)
  by Iain M. Cockburn
  (ReDIF-chapter, nbr:nberch:12367)
• The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity
  NBER Chapters, National Bureau of Economic Research, Inc (2013)
  by Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro
  (ReDIF-chapter, nbr:nberch:13094)
• The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis
  NBER Chapters, National Bureau of Economic Research, Inc (2018)
  by Iain M. Cockburn & Rebecca Henderson & Scott Stern
  (ReDIF-chapter, nbr:nberch:14006)
• Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry
  NBER Chapters, National Bureau of Economic Research, Inc (2007)
  by Iain M. Cockburn & Megan J. MacGarvie
  (ReDIF-chapter, nbr:nberch:3045)
• Hedonic Analysis of Arthritis Drugs
  NBER Chapters, National Bureau of Economic Research, Inc (2001)
  by Iain M. Cockburn & Aslam H. Anis
  (ReDIF-chapter, nbr:nberch:7637)
• Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
  NBER Chapters, National Bureau of Economic Research, Inc (1998)
  by Ernst R. Berndt & Iain M. Cockburn & Douglas L. Cocks & Arnold M. Epstein & Zvi Griliches
  (ReDIF-chapter, nbr:nberch:9823)
• Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs
  NBER Working Papers, National Bureau of Economic Research, Inc (2004)
  by Paul D. Chwelos & Ernst R. Berndt & Iain M. Cockburn
  (ReDIF-paper, nbr:nberwo:10746)
• Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
  NBER Working Papers, National Bureau of Economic Research, Inc (2006)
  by Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson
  (ReDIF-paper, nbr:nberwo:12509)
• Entry and Patenting in the Software Industry
  NBER Working Papers, National Bureau of Economic Research, Inc (2006)
  by Iain M. Cockburn & Megan J. MacGarvie
  (ReDIF-paper, nbr:nberwo:12563)
• Patents and the Survival of Internet-related IPOs
  NBER Working Papers, National Bureau of Economic Research, Inc (2007)
  by Iain M. Cockburn & Stefan Wagner
  (ReDIF-paper, nbr:nberwo:13146)
• Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry
  NBER Working Papers, National Bureau of Economic Research, Inc (2007)
  by Iain M. Cockburn & Megan MacGarvie
  (ReDIF-paper, nbr:nberwo:13644)
• Not Invented Here? Innovation in Company Towns
  NBER Working Papers, National Bureau of Economic Research, Inc (2009)
  by Ajay K. Agrawal & Iain M. Cockburn & Carlos Rosell
  (ReDIF-paper, nbr:nberwo:15437)
• Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity
  NBER Working Papers, National Bureau of Economic Research, Inc (2012)
  by Ajay K. Agrawal & Iain M. Cockburn & Alberto Galasso & Alexander Oettl
  (ReDIF-paper, nbr:nberwo:17793)
• Price Indexes for Clinical Trial Research: A Feasibility Study
  NBER Working Papers, National Bureau of Economic Research, Inc (2013)
  by Ernst R. Berndt & Iain M. Cockburn
  (ReDIF-paper, nbr:nberwo:18918)
• The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity
  NBER Working Papers, National Bureau of Economic Research, Inc (2013)
  by Murray L. Aitken & Ernst R. Berndt & Barry Bosworth & Iain M. Cockburn & Richard Frank & Michael Kleinrock & Bradley T. Shapiro
  (ReDIF-paper, nbr:nberwo:19487)
• Deals Not Done: Sources of Failure in the Market for Ideas
  NBER Working Papers, National Bureau of Economic Research, Inc (2013)
  by Ajay Agrawal & Iain Cockburn & Laurina Zhang
  (ReDIF-paper, nbr:nberwo:19679)
• Patents and the Global Diffusion of New Drugs
  NBER Working Papers, National Bureau of Economic Research, Inc (2014)
  by Iain M. Cockburn & Jean O. Lanjouw & Mark Schankerman
  (ReDIF-paper, nbr:nberwo:20492)
• The Impact of Artificial Intelligence on Innovation
  NBER Working Papers, National Bureau of Economic Research, Inc (2018)
  by Iain M. Cockburn & Rebecca Henderson & Scott Stern
  (ReDIF-paper, nbr:nberwo:24449)
• Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents
  NBER Working Papers, National Bureau of Economic Research, Inc (1987)
  by Iain Cockburn & Zvi Griliches
  (ReDIF-paper, nbr:nberwo:2465)
• Is Distance from Innovation a Barrier to the Adoption of Artificial Intelligence?
  NBER Working Papers, National Bureau of Economic Research, Inc (2024)
  by Jennifer Hunt & Iain M. Cockburn & James Bessen
  (ReDIF-paper, nbr:nberwo:33022)
• Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers
  NBER Working Papers, National Bureau of Economic Research, Inc (1992)
  by Iain Cockburn & Murray Frank
  (ReDIF-paper, nbr:nberwo:4194)
• Generics and New Goods in Pharmaceutical Price Indexes
  NBER Working Papers, National Bureau of Economic Research, Inc (1993)
  by Zvi Griliches & Iain Cockburn
  (ReDIF-paper, nbr:nberwo:4272)
• Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry
  NBER Working Papers, National Bureau of Economic Research, Inc (1993)
  by Rebecca Henderson & Iain Cockburn
  (ReDIF-paper, nbr:nberwo:4466)
• Public-Private Interaction and the Productivity of Pharmaceutical Research
  NBER Working Papers, National Bureau of Economic Research, Inc (1997)
  by Iain Cockburn & Rebecca Henderson
  (ReDIF-paper, nbr:nberwo:6018)
• Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
  NBER Working Papers, National Bureau of Economic Research, Inc (1997)
  by Ernst R. Berndt & Iain M. Cockburn & Douglas L. Cocks & Arnold Epstein & Zvi Griliches
  (ReDIF-paper, nbr:nberwo:6182)
• Hedonic Analysis of Arthritis Drugs
  NBER Working Papers, National Bureau of Economic Research, Inc (1998)
  by Iain M. Cockburn & Aslam H. Anis
  (ReDIF-paper, nbr:nberwo:6574)
• Balancing Incentives: The Tension Between Basic and Applied Research
  NBER Working Papers, National Bureau of Economic Research, Inc (1999)
  by Iain Cockburn & Rebecca Henderson & Scott Stern
  (ReDIF-paper, nbr:nberwo:6882)
• The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research
  NBER Working Papers, National Bureau of Economic Research, Inc (1999)
  by Iain Cockburn & Rebecca Henderson & Scott Stern
  (ReDIF-paper, nbr:nberwo:7359)
• Do Patents Matter?: Empirical Evidence after GATT
  NBER Working Papers, National Bureau of Economic Research, Inc (2000)
  by Jean O. Lanjouw & Iain Cockburn
  (ReDIF-paper, nbr:nberwo:7495)
• Are All Patent Examiners Equal? The Impact of Examiner Characteristics
  NBER Working Papers, National Bureau of Economic Research, Inc (2002)
  by Iain M. Cockburn & Samuel Kortum & Scott Stern
  (ReDIF-paper, nbr:nberwo:8980)
• University Research, Industrial R&D, and the Anchor Tenant Hypothesis
  NBER Working Papers, National Bureau of Economic Research, Inc (2002)
  by Ajay Agrawal & Iain M. Cockburn
  (ReDIF-paper, nbr:nberwo:9212)
• Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital
  NBER Working Papers, National Bureau of Economic Research, Inc (2003)
  by Ajay Agrawal & Iain Cockburn & John McHale
  (ReDIF-paper, nbr:nberwo:9950)
• Patent thickets, licensing and innovative performance
  Industrial and Corporate Change, Oxford University Press and the Associazione ICC (2010)
  by Iain M. Cockburn & Megan J. MacGarvie & Elisabeth Müller
  (ReDIF-article, oup:indcch:v:19:y:2010:i:3:p:899-925)
• The Economics of Reproducibility in Preclinical Research
  PLOS Biology, Public Library of Science (2015)
  by Leonard P Freedman & Iain M Cockburn & Timothy S Simcoe
  (ReDIF-article, plo:pbio00:1002165)
• Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery
  RAND Journal of Economics, The RAND Corporation (1996)
  by Rebecca Henderson & Iain Cockburn
  (ReDIF-article, rje:randje:v:27:y:1996:i:spring:p:32-59)
• Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins
  RAND Journal of Economics, The RAND Corporation (1997)
  by Sara Ellison Fisher & Iain Cockburn & Zvi Griliches & Jerry Hausman
  (ReDIF-article, rje:randje:v:28:y:1997:i:autumn:p:426-446)
• A Mixed Poisson Regression Model for Analysis of Patent Data
  Computing in Economics and Finance 1996, Society for Computational Economics ()
  by Peiming Wang & Iain Cockburn & Martin L. Puterman
  (ReDIF-paper, sce:scecf6:_049)
• Canada’s Patent Productivity Paradox: Recent Trends and Implications for Future Productivity Growth
  International Productivity Monitor, Centre for the Study of Living Standards (2023)
  by Iain Cockburn & Megan MacGarvie & John McKeon
  (ReDIF-article, sls:ipmsls:v:45:y:2023:5)
• The Impact of Incremental Innovation in Biopharmaceuticals
  PharmacoEconomics, Springer (2006)
  by Ernst Berndt & Iain Cockburn & Karen Grépin
  (ReDIF-article, spr:pharme:v:24:y:2006:i:2:p:69-86)
• Faster, smaller, cheaper: an hedonic price analysis of PDAs
  Applied Economics, Taylor & Francis Journals (2008)
  by P. D. Chwelos & E. R. Berndt & I. M. Cockburn
  (ReDIF-article, taf:applec:v:40:y:2008:i:22:p:2839-2856)
• Diffusion of New Drugs in the Post-TRIPS Era
  International Journal of the Economics of Business, Taylor & Francis Journals (2011)
  by Ernst Berndt & Nathan Blalock & Iain Cockburn
  (ReDIF-article, taf:ijecbs:v:18:y:2011:i:2:p:203-224)
• The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions
  Innovation Policy and the Economy, University of Chicago Press (2010)
  by Iain M. Cockburn & Matthew J. Slaughter
  (ReDIF-article, ucp:ipolec:doi:10.1086/605855)
• Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery
  Working Papers, Department of Economics, University of Lancaster ()
  by Rebecca Henderson & Iain Cockburn
  (ReDIF-paper, wuk:lanedp:ec25/94)
• Patent thickets, licensing and innovative performance
  ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research (2009)
  by Cockburn, Iain M. & MacGarvie, Megan J. & Müller, Elisabeth
  (ReDIF-paper, zbw:zewdip:08101r)
• Patent Thickets, Licensing and Innovative Performance
  ZEW Discussion Papers, ZEW - Leibniz Centre for European Economic Research (2008)
  by Müller, Elisabeth & MacGarvie, Megan J. & Cockburn, Iain M.
  (ReDIF-paper, zbw:zewdip:7475)